Insider Transactions in Q2 2023 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
17,984
-6.61%
|
$395,648
$22.09 P/Share
|
|
Jun 02
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
31,272
-5.12%
|
$656,712
$21.92 P/Share
|
|
Jun 01
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
31,272
-9.26%
|
$687,984
$22.09 P/Share
|
|
May 31
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
31,272
-8.48%
|
$656,712
$21.87 P/Share
|
|
May 30
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
31,271
-7.82%
|
$656,691
$21.9 P/Share
|
|
May 18
2023
|
Michael Thomas Heffernan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+20.57%
|
-
|
|
May 18
2023
|
Neil F. Mc Farlane Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+19.03%
|
-
|
|
May 18
2023
|
Rita J. Balice Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+20.15%
|
-
|
|
May 18
2023
|
Garen G Bohlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|
|
May 18
2023
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+12.59%
|
-
|
|
May 18
2023
|
Gwen A Melincoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|
|
May 18
2023
|
John A. Fallon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.2%
|
-
|
|
May 18
2023
|
John Gordon Freund Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|